Mode
Text Size
Log in / Sign up

Vascular Dementia

Part of Dementia

12 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Vascular Dementia

21 trials tracked for Vascular Dementia: 4 in phase 3 or 4 and 1 with published results. The most-cited published study has 70 citations.

21Trials tracked
4Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 2 Phase 2 1 Other / NA 16
  1. Phase 3 The Healthy Patterns Sleep Study Completed · 70 cited
  2. Phase 4 A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia Completed
  3. Phase 4 Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) Completed
  4. Phase 3 Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia. Completed
  5. Phase 2 Effect of Insulin Sensitizer Metformin on AD Biomarkers Completed
  6. N/A Zolpidem CR and Hospitalized Patients With Dementia Completed
Show 15 more trials
  1. N/A Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers Completed
  2. N/A Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial Completed
  3. N/A Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers Completed
  4. N/A SAFE at Home: A Service to Provide Social Engagement to Community-Dwelling Persons With Dementia Completed
  5. N/A LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers Completed
  6. N/A Optimizing Dementia Care Completed
  7. N/A Non-Interventional Study With Aricept® Evess Completed
  8. N/A The BRAIN App: Building Relationships Using Artificial Intelligence and Nostalgia Completed
  9. N/A Rural Dementia Caregiver Project Completed
  10. N/A Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study Completed
  11. N/A All About Me: An Intervention to Ease the Transition to Long Term Care Completed
  12. N/A Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support: Completed
  13. N/A Care Ecosystem: Navigating Patients and Families Through Stages of Care Completed
  14. N/A Care of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (PACE) Completed
  15. N/A Innovations in Dementia Empowerment and Action Completed

Showing the 21 most-cited and recently-updated of 21 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Vascular Dementia: what the trials found

Pharmacological interventions for vascular dementia include Cerebrolysin, which demonstrated a significant improvement in ADAS-cog+ scores at week 24 compared to baseline (p < 0.0001) 3. Prospekta was associated with statistically significant improvements in MoCA scores (p = 0.0316) and Clinical Global Impression Efficacy Index (CGI-EI) scores (p = 0.0018), though it did not significantly impact Neuropsychiatric Inventory-Clinician (NPI-C) scores 5.

Behavioral and engagement programs, such as SAFE at Home, resulted in significant changes in both constructive and passive engagement on the Menorah Park Engagement Scale [10, 11].

Recent results — preliminary, needs further review

  • Cognitive Stimulation Therapy (CST) referral showed a statistically significant difference in cognitive impairment scores (p < 0.05), though only a small percentage of patients who were referred actually completed the therapy 1.
  • The ADRD-PC Program resulted in a statistically significant increase in symptom treatment for patients (p < 0.001), but did not show significant differences in hospital transfers or physical symptom control 7.
  • A Building Better Caregivers Workshop was evaluated regarding caregiver depression, stress, and self-efficacy, though specific p-values were not provided for these outcomes 8.

For the clinician treating this condition

  • Cerebrolysin and Prospekta have shown statistically significant improvements in cognitive assessment scales (ADAS-cog+ and MoCA respectively) [3, 5].
  • SAFE at Home programs are associated with measurable changes in patient engagement levels [10, 11].
  • While referral for Cognitive Stimulation Therapy is linked to improved outcomes, low completion rates may impact clinical implementation 1.

AI synthesis of 5 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Dementia

Related studies from across the Dementia family.

Higher GrimAge epigenetic age acceleration is significantly associated with higher dementia risk
Neurology Meta-analysis
Higher GrimAge epigenetic age acceleration is significantly associated with higher dementia risk GrimAge metric shows link to increased risk of dementia
This meta-analysis of 46,365 individuals with neurodegenerative diseases found that only the GrimAge metric showed a significant association…
One specific biological age clock, known as GrimAge, showed a link to higher dementia risk in a large study of over 46,000 people.
Social isolation and loneliness are significant determinants of cognitive decline and dementia risk in older adults
Psychiatry Sys. Review
Social isolation and loneliness are significant determinants of cognitive decline and dementia risk in older adults Social isolation and loneliness increase risk of dementia in older adults
This systematic review examines the impact of social isolation and loneliness on cognitive decline and dementia risk in older adults. The au…
Loneliness and social isolation are linked to faster cognitive decline and a higher risk of dementia in older adults.
Chronic pain is associated with poorer executive functioning and processing speed in dementia patients
Anesthesiology & Pain Medicine Sys. Review
Chronic pain is associated with poorer executive functioning and processing speed in dementia patients Chronic pain is linked to poorer thinking in people with dementia
This systematic scoping review explores the relationship between chronic pain and cognitive performance in individuals with dementia. The re…
Living with chronic pain may make it harder for people with dementia to manage tasks and process information quickly.
HMB and vitamin D enriched protein supplements may support muscle and cognitive health in dementia
Geriatrics & Aging Sys. Review
HMB and vitamin D enriched protein supplements may support muscle and cognitive health in dementia Nutrition Drink May Help Muscles In Dementia Patients
This narrative review examines the role of high protein oral nutritional supplements enriched with HMB and vitamin D for older adults at ris…
A high protein drink with HMB and vitamin D may support muscle health in older adults with dementia, but brain benefits remain unproven.
HMGB1 acts as a progression-associated inflammatory amplifier in Alzheimer's, Parkinson's, and ALS models
Neurology Sys. Review
HMGB1 acts as a progression-associated inflammatory amplifier in Alzheimer's, Parkinson's, and ALS models New research explores a protein linked to several brain diseases
This narrative review explores the role of HMGB1 in various neurodegenerative diseases including Alzheimer's, Parkinson's, and ALS. The auth…
A specific protein called HMGB1 may act as a driver of inflammation in conditions like Alzheimer's and Parkinson's disease.
HRSN assessment tools lack sufficient psychometric testing and reliability data for geriatric populations
Neurology Meta-analysis
HRSN assessment tools lack sufficient psychometric testing and reliability data for geriatric populations New Review Highlights Gaps in Alzheimer's and Dementia Care Tools
This systematic review of 7 studies evaluated the methodological rigor and psychometric properties of HRSN assessment tools in older adults.…
Current tools used to measure social needs for seniors with dementia lack enough testing to ensure they are accurate for older adults.
Scoping review protocol to map living arrangement and carer variables in dementia help-seeking research
Primary Care & Family Medicine Sys. Review
Scoping review protocol to map living arrangement and carer variables in dementia help-seeking research Mapping How Living Arrangements Affect Help Seeking for Dementia
This is a scoping review protocol, not a completed study, that will map how living arrangement and supporter or carer related variables are …
New research plans to map how living situations and family support impact how people with memory problems seek a diagnosis for dementia.
Impact of Receptor Stimulating Antihypertensive Medications on Alzheimer Disease Risk in Elderly Patients
Neurology RCT
Impact of Receptor Stimulating Antihypertensive Medications on Alzheimer Disease Risk in Elderly Patients Certain blood pressure medications may link to lower dementia risk
Retrospective analysis suggests receptor-stimulating antihypertensives may correlate with lower ADRD incidence compared to receptor-inhibiti…
A large study of over 1.5 million seniors suggests specific blood pressure medications may be linked to lower rates of dementia and cognitiv…
Comprehensive dementia care interventions improve caregiver self-efficacy in those with lower baseline scores
Physical Medicine & Rehab RCT
Comprehensive dementia care interventions improve caregiver self-efficacy in those with lower baseline scores Comprehensive Care Programs May Improve Confidence for Dementia Caregivers
This secondary analysis of a randomized pragmatic clinical trial involved 2037 caregivers of community-dwelling persons living with dementia…
Caregivers of people with dementia can improve their self-efficacy and confidence through comprehensive care programs.
Non-pharmacological interventions for sleep disturbances in mild cognitive impairment and early dementia provide management guidance
Palliative Care Guideline
Non-pharmacological interventions for sleep disturbances in mild cognitive impairment and early dementia provide management guidance Sleep Care Plan for Early Dementia: Best Evidence
This integrative review and guideline identifies 44 evidence items across 11 themes for managing sleep disturbances in patients with mild co…
A new review maps 44 best evidence items for managing sleep problems in mild cognitive impairment and early dementia.
Increased Risk of Dementia Diagnosis Among Individuals Diagnosed With Bipolar Disorder
Psychiatry Meta-analysis
Increased Risk of Dementia Diagnosis Among Individuals Diagnosed With Bipolar Disorder Bipolar disorder linked to triple dementia risk
A large-scale meta-analysis identifies a significant correlation between bipolar disorder and an elevated risk of dementia diagnosis.
People with bipolar disorder face a higher risk of dementia, a new analysis finds. The link is strong but the evidence has limits.
Dementia prevalence 24.3% in older adults with psychotic disorders, meta-analysis finds
Psychiatry Meta-analysis
Dementia prevalence 24.3% in older adults with psychotic disorders, meta-analysis finds Dementia found in 1 in 4 older adults with psychotic disorders
This meta-analysis of older adults with psychotic disorders reports a pooled dementia prevalence of 24.3% (95% CI: 20.5%-28.5%), with high h…
A new analysis finds dementia in 24.3% of older adults with psychotic disorders, highlighting the need for better care planning.

Questions about Vascular Dementia

Is there a link between schizophrenia and the development of vascular dementia?

People with schizophrenia have a two- to threefold higher risk of developing dementia, including vascular dementia, due to shared biological factors and medical burdens.

Full answer →
How do antidiabetic drugs affect dementia risk in patients with diabetes?

Research shows that insulin, metformin, and pioglitazone lower dementia risk compared to placebo, while DPP4 inhibitors may increase vascular dementia risk compared to SGLT2 inhibitors.

Full answer →
Does having schizophrenia increase my chances of getting vascular dementia later?

Having schizophrenia increases your risk of developing dementia later in life by about two to three times, and this higher risk includes a specific increase in vascular dementia.

Full answer →